Skip to content

Clinical trials

Phase 1 Ureteral Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ureteral Neoplasms Phase: Phase 1 Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20111
20121
20153
20171
20181
20201
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting5
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
National Cancer Institute (NCI)3
M.D. Anderson Cancer Center2
Dr Anders Ullén1
H. Lee Moffitt Cancer Center and Research Institute1
Memorial Sloan Kettering Cancer Center1
Rahul Aggarwal1
University of Oklahoma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ureteral Neoplasms14
Urinary Bladder Neoplasms12
Urethral Neoplasms9
Carcinoma, Transitional Cell6
Carcinoma, Non-Small-Cell Lung5
Neoplasm Metastasis4
Ovarian Neoplasms3
Pancreatic Neoplasms3
Squamous Cell Carcinoma of Head and Neck3
Urologic Neoplasms3

Trials

Showing 51 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.